Global Asthma & Copd Market set to grow to $47bn by 2024, according to Visiongain report.
London, UK, March 29, 2019 (GLOBE NEWSWIRE) -- The asthma and COPD market benefits from increasing prevalence of respiratory diseases, coupled with the high economic cost of those diseases. The industry will also have more biologics and synthetic anti- …